---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-112267"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:11:33.559290+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Arcadia CFO Mark Kawakami resigns; CEO Schaefer adds interim CFO role

## Summary
- CFO Mark Kawakami resigns effective September 12, 2025; not due to any disagreement with the Company or auditors.
- CEO Thomas J. Schaefer appointed interim CFO and principal accounting officer, effective upon Kawakami's resignation.
- Schaefer previously served as CFO from January 2023 to July 2024; no compensation change for the additional role.
- Schaefer will be available as an advisor after his departure; transition proceeds smoothly.

## SEC filing metadata
- accession: 0000950170-25-112267
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017025112267/0000950170-25-112267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017025112267/rkda-20250826.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-112267
- JSON: https://secwatch.observer/filing/0000950170-25-112267.json
- Plain text: https://secwatch.observer/filing/0000950170-25-112267.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.